Skip to main content
MEKICS Co., Ltd logo

MEKICS Co., Ltd — Investor Relations & Filings

Ticker · 058110 ISIN · KR7058110008 KO Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2020-03-13 Proxy Solicitation & In…
Country KR South Korea
Listing KO 058110

About MEKICS Co., Ltd

https://mek-ics.com/eng/Index

MEKICS Co., Ltd. is a medical technology company specializing in the development and commercialization of respiratory care solutions. Its product portfolio includes ventilators for intensive care and transport, high-flow oxygen therapy systems, patient monitors, and continuous positive airway pressure (CPAP) devices. Leveraging proprietary respiratory technologies, MEKICS provides solutions for both hospital and homecare environments. The company emphasizes continuous research and development, product safety, and quality to innovate and serve the global respiratory care market.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation & Information Statement' (PSI) filed by (주)멕아이씨에스 (MEKICS Co., Ltd.) for their upcoming Annual General Meeting (AGM). It contains details on the meeting date, agenda items (such as the approval of financial statements), information about the solicitors, and proxy voting procedures. While it includes financial statements, these are provided as supporting information for the shareholders to review prior to the vote, which is characteristic of a proxy statement rather than an annual report or earnings release.
2020-03-13 Korean
주권매매거래정지(우회상장여부 및 요건충족확인)
Delisting Announcement Classification · 95% confidence The document is a short regulatory notice regarding the suspension of stock trading for (주)멕아이씨에스 due to a review of a potential backdoor listing. It cites specific KOSDAQ market regulations and provides the duration of the suspension. As it is a regulatory announcement regarding trading status that does not fit into specific categories like delisting or share issuance, it falls under the general regulatory filing category.
2020-02-12 Korean
주식교환ㆍ이전결정(종속회사의주요경영사항)
M&A Activity Classification · 100% confidence The document is a formal regulatory announcement regarding a 'Stock Exchange/Transfer Decision' (주식교환ㆍ이전 결정) between MEKICS Co., Ltd. and its subsidiary, MEK Healthcare. This type of corporate restructuring, involving share exchange ratios, board approval, and merger-related details, falls under M&A activity. In the provided taxonomy, 'TAR' (M&A Activity) is the appropriate category for merger proposals, takeovers, and corporate restructuring involving share exchanges.
2020-02-12 Korean
주권매매거래정지해제(우회상장 미해당)
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice from the KOSDAQ exchange regarding the lifting of a trading suspension for the company MEKICS. It cites specific exchange regulations and provides the effective date of the trading resumption. Since it is a regulatory announcement regarding market status rather than a financial report, management update, or corporate action, it falls under the general regulatory filings category.
2020-02-12 Korean
[첨부추가]주요사항보고서(주식교환ㆍ이전결정)
Share Issue/Capital Change Classification · 98% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding a 'Stock Exchange/Transfer Decision' (주식교환ㆍ이전 결정). This is a formal regulatory filing detailing a corporate restructuring (M&A activity) where one company becomes a wholly-owned subsidiary of another. In the context of the provided categories, this fits best under M&A Activity (TAR) as it details the exchange ratio, valuation, and strategic purpose of the merger/acquisition.
2020-02-12 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 95% confidence The document is a regulatory filing from a Korean company (MEK-ICS) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement for listed companies in Korea to report preliminary financial results before the final audit. Since it provides key financial highlights and reasons for the change, it fits the definition of an Earnings Release (ER). FY 2019
2020-02-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.